The isolation of human bronchial epithelial (HBEC) and fibroblastic cells (HBFC) from biopsies of asthmatic and non-asthmatic volunteers provided unique cellular materials to be used for the production of bioengineered bronchial equivalents (BE) in vitro. The HBEC are grown on a mesenchymal layer seeded with HBFC and the BE can be maintained for at least 15 days in culture. Under the BE culture conditions established previously, HBEC undergo differentiation into ciliated and goblet cells, within a pseudostratified organization comparable to human bronchi. We published previously the results from histologic and functional analyses of such BE produced exclusively using non-asthmatic HBEC and HBFC. We report here the comparative analyses of BE produced with non-asthmatic and asthmatic living HBEC and HBFC (naBE and aBE, respectively). Our data indicated that all asthmatic HBEC populations grown on a mesenchymal layer, containing nonasthmatic HBFC, slowly reached a confluent state but then detached from the matrix upon culture time. These BE appear to be very good models to study the mechanisms involved in asthma in vitro.
Introduction
In our modern society, thousands of people suffer from mild to severe asthma. This bronchial disorder is mostly associated with mucosal inflammation and airway hyperresponsiveness (Jeffery et al., 1989; Boulet et al., 1993) . Histologic analyses of bronchial biopsies taken on asthmatic patients report an apparent basement membrane thickening most likely caused by sub-epithelial fibrosis. It is postulated that fibroblasts, involved in collagen synthesis and remodelling, could be responsible for the acute fibrosis in response to cytokines secreted by inflammatory or epithelial cells (Brewster et al., 1990; Roche, 1991; Gauldie et al., 1992) . Another major change in the structural properties of asthmatic bronchi is their partial or complete desquamation upon the evolution of the disease (Jeffery et al., 1989) . Up to now, the alterations of the bronchial tissues of asthmatic subjects remain poorly understood and the various hypotheses raised on the putative mechanisms responsible for the maintenance and the progression of these changes have to be assessed.
Besides live animals (often rats and dogs) (DiCosmo et al., 1995; Chung, 1996; Widdicombe, 1996; Shichinoke et al., 1996) , several research groups use animal bronchial tissues (Opazo-Saez and Pare, 1994; Baeza-Squiban et al., 1994; Davenport and Nettesheim, 1996) or cells grown in monolayers (De Jong et al., 1994; Gray et al., 1996) as experimental models, to study various aspects of asthma in vitro. To overcome interindividual variations among animals used as experimental models, the number of subjects needed to perform each study has to be quite considerable. Moreover, animal models are complex and it becomes sometimes difficult to control all physiologic parameters which may modulate the results of comparative studies between non-asthmatic and asthmatic groups. In addition, some limitations are associated with bronchial cell monolayers, particularly because heterotypic cellular interactions are difficult to reproduce under these culture conditions.
Over the last decade, bioengineering has enlarged the possibilities to develop tissue models (Langer and Vacanti, 1993) by combining the conventional cell culture approaches to a concept according to which most cells can adopt specific three-dimensional orientation and organization in an extracellular matrix, in response to proper stimuli induced mechanically in vitro. This concept has been confirmed in various bioengineered tissues produced in culture, notably in skin, blood vessels and ligaments (Bellows et al., 1982; Bouvard et al., 1992; Lopez-Valle et al., 1992; L'Heureux et al., 1993; Auger et al., 1995;  
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Human bronchial cell isolation
The human bronchial cells were isolated by a new enzymatic technique and amplified in culture according to methods developed in our laboratory (Goulet et al., 1996a) . Briefly, the processing was performed within 2-3 hours following the bronchoscopy. Collagen being the major constituent of bronchi matrix, collagenase was chosen to digest the collagen matrix of the biopsies. The human bronchial biopsies were digested in 0.1% (0.2 U/ml) collagenase H (Boehringer Mannheim, Montreal, Canada) prepared in Dulbecco-Vogt modification of Eagles medium (DMEM) culture medium containing 10mM CaCl 2 without any supplement. Tissues were digested overnight at 4°C because a collagenase digestion performed overnight at 37°C would reduce cell yield and viability. Homogenates were centrifuged for 10 min at 300 g and the cell pellets were resuspended in DMEM supplemented with 10% fetal calf serum (FCS).
All cells were plated in several 35-mm Petri dishes. The cultures were monitored daily and the dishes containing epithelial cells were selected for addition of some lethally irradiated 3T3 feeder cells (like it is done for skin epithelial cells, see Green et al., 1979) . This technique allows the selection of pure epithelial cell populations (Goulet et al., 1996a) . After 8-12 days in culture, bronchial epithelial cells had reached 85% confluency and were ready to be stored and subcultured. The bronchial epithelial cells were cultured according to the method established for human keratinocytes , originally described by Green et al. (1979) , in a combination of DMEM with Ham's F12 in a 3:1 proportion (Gibco BRL, Burlington, Canada), supplemented with 24.3 µg/ml adenine (Sigma Chemicals, St-Louis, MO), 10 ng/ml human epidermal growth factor (EGF, Austral Biological, San Ramon, CA), 5 µg/ml bovine crystallized insulin, 5 µg/ml human transferrin (Boehringer Mannheim, Laval, Canada), 2x10-9 M 3,3',5', triiodo-L-thyronin (Sigma), 0.4 mg/ml hydrocortisone (Calbiochem, La Jolla, CA), 10-10 M cholera toxin (ICN Biochemicals, Montreal, Canada), 10% reconstituted newborn calf serum (Immunocorp Sciences inc., Montreal, Canada) 100 IU/ml penicillin G and 25 µg/ml gentamicin (Sigma). Bronchial fibroblasts were obtained in the dishes which did not contain epithelial cells. They were cultured in DMEM supplemented with 10% fetal calf serum, 100 IU/ml penicillin G and 25 µg/ml gentamicin. They also reached 85% confluency after a week. The culture media was changed three times a week. All cultures were kept in an 8% CO 2 atmosphere at 37°C.
Human bronchial cell viability
The viability of epithelial cells over 3-4 passages and of fibroblasts over 8-9 passages, were comparable between asthmatic and non-asthmatic cell populations (over 85% viability). However, the yields of epithelial cells obtained from asthmatic biopsies were about 60% lower in primary culture, compared to non-asthmatic biopsies. That is expected, since the epithelia of the asthmatic biopsies are often poorer in cells and sometimes disorganized. Moreover, considering that we isolated the cells from 6-10 microbiopsies (1-2 mm-diameter), we believe that our Goulet et al., 2000; Chakir et al., 2001; Paquette et al., 2003) .
Thus, we have used several populations of the human bronchial cells isolated in our laboratory (Goulet et al., 1996a) from bronchial biopsies of asthmatic and non-asthmatic subjects, in an attempt to produce three-dimensional bronchial equivalents (BE) in vitro. For the first time, a bilayered BE containing human bronchial epithelial (HBEC) and fibroblastic cells (HBFC) isolated from asthmatic biopsies was obtained and maintained in culture for at least 15 days. An asthmatic HBEC layer grown on a mesenchymal counterpart seeded with asthmatic HBFC formed a BE referred to as asthmatic BE (a/aBE). Similarly, the non-asthmatic BE (na/naBE) was produced by combining non-asthmatic HBEC and HBFC in their respective layers. The interesting results from comparative analyses of these BEs are described in the present report.
Materials and Methods Subjects
Non-smoking asthmatic and normal subjects aged from 20 to 45 years, evaluated at the Laval Hospital asthma clinic, were enrolled in the study. The study was approved by the local Ethics Committee and subjects had given informed written consent. The normal subjects had a PC 20 value (metacholine provocation, see below) over 16 mg/ml. All asthmatic subjects had a diagnosis of asthma according to the American Thoracic Society criteria (American Thoracic Society, 1987) . All were atopic with at least one positive response to common allergens on allergy skin prick tests. Their asthma required only an inhaled β2 agonist agent on demand. None of the subjects reported a respiratory infection or an increase in asthma symptoms in the month preceding the study. They were not currently exposed to allergens to which they were sensitized apart from house-dust.
Spirometry and response to inhaled methacholine were measured according to standardized procedures using aerosols generated with a Wright's nebulizer at tidal breathing for periods of 2 minutes (output = 0.13 ml/min) (Juniper et al., 1991) . The provocative concentration of methacholine inducing a 20% fall in FEV 1 , the PC 20 , was determined. Skin prick tests were performed with a battery of common airborne allergens. Atopy was considered to be present if there was one or more positive response (> 3 mm wheal) to the inhalant allergens, with a positive reaction to histamine phosphate but not the diluent.
Bronchoscopy and bronchial biopsies
Before the bronchoscopy, a 200 µg dose of salbutamol was given using a metered-dose inhaler. All subjects received oxygen at 5 l / min by nasal catheter during bronchoscopy. After local anaesthesia of the throat, larynx and bronchi with 2% and 4% xylocaine, the flexible bronchoscope (Olympus OES 10 fiberscope, Olympus, Markham, Canada) was introduced into the bronchial tree and ten bronchial biopsies were taken from the carinae of the right upper and middle lobes and the segmental bronchi of the upper and lower lobes on both sides using conventional forceps. Vital signs, electrocardiograph and oximetry were recorded throughout the procedure. method can be considered as successful (Goulet et al., 1996a) .
Human bronchial cell markers
The respective morphological features of each cell type are very different and were confirmed by specific immunolabeling. Epithelial cells were immunolabeled with anti-keratin antibodies and fibroblasts were labeled with antivimentin antibodies (Goulet et al., 1996a) .
Production of three-dimensional human bronchial equivalents (BEs)
Step 1: Preparation of the mesenchymal layer of the BEs. The BEs were produced according to the method published by Auger et al. (1995) , with a few modifications. Briefly, a mixture of bovine Type I collagen (1.5 mg/ml) was prepared by dissolving the powder overnight at 4°C in sterile 0.017 M acetic acid. A solution of 0.84 ml of DMEM 2.7X containing 200 IU/ml penicillin G and 50 µg/ml of gentamicin, pH 8.0, was mixed with a second solution containing 0.56 ml of FCS, 1.43 ml of the stock collagen solution, 30 µl of NaOH 0.7N and 0.15 ml of a HBFC suspension (1 X 106 cells/ml). This mixture was quickly distributed in a bacteriological Petri dish (35-mm diameter) already containing the peripheral anchorage (sterile ring of Whatman paper), to produce the mesenchymal layers of each BE. The anchorage method, which prevents collagen lattice contraction by the cells, was used as described previously (L'Heureux et al., 1993; Auger et al., 1995) . Non-asthmatic (na) and asthmatic (a) HBFC were seeded individually in different mesenchymal layers to produce naBE and aBE, respectively. The mesenchymal layers of the BE were covered with 2 ml of DMEM supplemented with 10% FCS, 100 IU/ml penicillin G and 25 mg/ml gentamicin following collagen polymerization and cultured in this medium until their epithelialization.
Step 2: Epithelialization of the BE under submerged culture conditions. Four days later, the epithelialization was performed by seeding HBEC (8x105 cells / BE) on the mesenchymal equivalents, maintained under submerged culture conditions until a confluent epithelial cell layer was obtained. Again, non-asthmatic and asthmatic HBEC were seeded on the corresponding mesenchymal counterparts. In some groups of BEs, HBEC from non-asthmatic source were seeded on mesenchymal layers containing asthmatic HBFC and vice versa. During the first 3 days after epithelia1ization, all BEs were cultured in the medium used for the culture of HBEC (see the section Human bronchial cell isolation). On the fourth day after epithelialization, the BEs were cultured in serumfree medium, supplemented with 24.3 mg/ml adenine, 10 ng/ ml human EGF, 5 mg/ml bovine crystallized insulin, 5 mg/ ml human transferrin, 2x10 M retinoic acid (RA). The culture media were changed daily.
Step 3: Culture at the air-liquid interface: The BEs were raised at the air-liquid interface as soon as a confluent layer of HBEC had covered their mesenchymal layers (6-8 days after epithelialization, depending on cell growth rates that could slightly vary from one experiment to another). The BEs were placed on Petri dishes containing an internal elevated support (Falcon No 3037). They were cultured at the airliquid interface for equal number of days (a period varying from 5 to 7 days, according to each experiment), in the same media used under submerged conditions, but in the absence of EGF and cholera toxin since these growth factors enhance the production of gelatinases by the cells, which degrade the collagen matrix of the mesenchymal layer in culture at the air-liquid interface (Auger et al., 1995) . The culture media were changed daily. Each experiment was done 3 times on at least 3 samples per group of BEs tested.
Conditioned medium
The conditioned medium (CM) was obtained from confluent non-asthmatic HBFC populations. The cells were grown until they had reached 95% confluence in a 75 cm 2 Falcon culture dish. During the conditioning period of 7 hrs, the HBFC were kept in 12 ml of the same serum-free medium, used to culture the BEs under submerged conditions. Each sample of fresh CM was passed through a 0.22 µm Millipore low-binding protein filter in order to eliminate all cellular fragments before being transferred on the various groups of BEs. Fresh CM was produced and used daily, without any dilution.
Histological analysis
All BEs were fixed with Bouin's solution and then embedded in paraffin. The 4 µm thick sections were stained using two different methods: the hematoxylin, phloxine and saffron staining and the PAS staining. To eliminate cross-reaction with endogenous glycogen in situ, some BE sections were digested before PAS staining with a solution of 0.5% maltase (Fisher) in phosphate-buffered saline (PBS) for 30 min at 37°C and washed 10 min with distilled water. At least 10 tissue sections were analyzed for each BE tested. We observed the entire sections to take representative pictures.
Electron microscopy
Some BEs were also processed and mounted for transmission and scanning electron microscope analyses as previously described . Briefly, the samples were fixed with a solution of 2% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.5 for 24 hrs, postfixed with 1% osmium tetroxide, dehydrated with ethanol and coated with gold (Sputtercoater, Nanotech, Manchester, U.K.). Micrographs were made using Polaroid Polapan 400. A JEOL JSM-35CF scanning electron microscope was used.
Gelatinase activity assay
The active gelatinases secreted in the BE culture media were semi-quantitatively analyzed by zymography, according to the method described previously (Auger et al., 1995) . Briefly, one sample of all BE culture supernatants were collected daily, filtered and immediately frozen at -70°C until use. At least 5 samples collected for each BE, during culture at the air-liquid interface, were analyzed by zymography. A constant volume (25 µl) of each sample diluted in equal volume of 2x sample buffer was resolved under non-reducing conditions by SDS-PAGE (Laemmli, 1970) . The gels were rinsed and equilibrated Figure 1 . Histological analyses of different bilayered BE cultured for 6 days at the air-liquid interface in serum-free medium supplemented with RA. Masson trichrome staining of a BE produced with both non-asthmatic HBEC and HBFC (A), non-asthmatic HBEC and asthmatic HBFC (B-E), both asthmatic HBEC and HBFC (F-H), and asthmatic HBEC and non-asthmatic HBFC (I). The dashed line indicates the border of the mesenchymal layers in A, D-E, H-I. Note the holes between the epithelial and the mesenchymal layers (arrows) and the cell debris under the basement membrane (arrowheads) of the BEs produced with asthmatic HBEC (F-I). Scale bar 36µm. Human asthmatic bronchial equivalents in the proper buffer systems and put overnight at 37°C in digestion buffer (50 mM Tris, pH 7.4, containing 10 mM CaCl 2 and 100 mM NaCl), under slow agitation. The gels were fixed with a 30% methanol solution containing 10% acetic acid and stained with 0.05% Coomassie blue prepared in the fixative. The gels were photographed and scanned.
Results
Histological analysis of BEs
Histological analyses were performed on 4 different groups of BEs cultured for 6 days at the air-liquid interface. One of the advantages of our bilayered BE is the possibility to produce different types of bioengineered tissues, containing HBEC and HBFC isolated from the same biopsies or from biopsies of different subjects (non-asthmatic or asthmatic). Thus, to evaluate and compare the growth of nonasthmatic and asthmatic HBEC on mesenchymal layers containing asthmatic and non-asthmatic HBFC, the four types of BEs were produced and analyzed.
The first group of BEs was produced using both nonasthmatic HBEC and HBFC, na/naBEs. Masson trichrome staining of a na/naBEs is shown in Figure lA . The second group of BEs was produced by seeding non-asthmatic HBEC on a mesenchymal layer containing asthmatic HBFC, na/aBEs (Fig. 1, B-E) . The third group of BEs was produced using both asthmatic HBEC and HBFC, a/aBEs (Fig.  1, F-H) . In the fourth group of BEs, asthmatic HBEC were grown on a mesenchymal layer seeded with non-asthmatic HBFC, a/naBEs (Fig. 1I) .
The thickness of the mesenchymal layers of the different BE groups showed differences upon culture time. As shown in figure 1 , the mesenchymal layers of some a/aBEs (Fig. 1, F-G ) and na/aBEs (Fig. 1 , B-C) were degraded more slowly at the air-liquid interface, than the mesenchymal counterpart of na/naBEs (Fig. lA) , and depending on the asthmatic HBFC population seeded in the different groups of a/aBEs and na/aBEs.
The non-asthmatic HBEC reached a confluent state on the mesenchymal layers populated with non-asthmatic and asthmatic fibroblasts: na/naBEs (Fig. 1A) and na/aBEs (Fig.  1, B-E) , respectively. However, these cells covered the mesenchymal layer of aBEs one day later than those seeded in naBEs (data not shown). Similarly, HBEC isolated from asthmatic subjects grew more slowly (in 8 days under submerged culture conditions) on all mesenchymal layers,
Figure 2. Macroscopic view of rhodanile red stained BEs (A and B). Non-asthmatic (A) and asthmatic (B) HBEC
were grown on a BE mesenchymal counterpart containing non-asthmatic HBFC in serum-free medium supplemented with RA for 8 days under submerged culture conditions. Photomicrograph taken under phase constrast microscopy of BE sections after 18 days under the same culture conditions (C and D). Note the confluent layer of non-asthmatic HBEC (C), compared to the compact colonies (arrowheads indicate their borders) of asthmatic HBEC (D) slowly detaching from the mesenchymal counterpart. Scale bars: A-B, 0.5cm; C-D, 9 µm. Human asthmatic bronchial equivalents populated with asthmatic HBFC (Fig, l, F-H ) and non-asthmatic HBFC (fig 1I) . However, after reaching a confluent state on the various mesenchymal counterparts, the asthmatic HBEC slowly started detaching in plates from the matrix, one or two days later. Some holes remained in the reconstructed epithelia thereafter, combined to the presence of cell debris observed under the basement membrane of all a/aBEs and a/naBEs (Fig. l, F-I) . Compared to the maintenance of a confluent epithelial layer of non-asthmatic HBEC on all BEs (Fig. 2A) , the striking detachment of the asthmatic HBEC could be seen macroscopically after rhodanile red staining in the corresponding BEs (Fig. 2B ). These observations were confirmed under phase constrast microscopy of BE sections, (Fig. 2, C-D) . Indeed, the confluent layer of non-asthmatic HBEC (Fig. 2C) , was very different from the compact colonies of asthmatic HBEC Figure 3 . Scanning electron microscopy analyses of ciliated HBEC in two different BE cultured for 7 days at the air-liquid interface. Photomicrograph of a small patch of asthmatic HBEC (a) remaining after the partial detachment of the epithelial layers on a BE mesenchymal layer seeded with asthmatic HBFC, shown at higher magnification (b) and compared to non-asthmatic HBEC (c) grown on a mesenchymal counterpart seeded with non-asthmatic HBFC. (1) and two different asthmatic populations of HBFC (2-3), cultured in serum-free medium supplemented with RA (2-3) and conditioned medium (CM) for 7 days under submerged conditions. Note the differences in the density of non-asthmatic HBEC observed in response to the HBFC isolated from non-asthmatic (1) and asthmatic (2-3) tissues, seeded in the mesenchymal counterparts of the different BE. Note the stimulatory effects of the addition of CM (conditioned by non-asthmatic HBFC) on the growth of HBEC seeded on the two mesenchymal layers containing the respective asthmatic HBFC used to produce the BE 2 and 3. Scale bars 0.5cm. (Fig. 2D) , that were slowly detaching from their mesenchymal counterpart.
Electron microscopy analyses of the various groups of BEs
Scanning electron microscopy analyses confirmed the partial detachment of the asthmatic HBEC from the mesenchymal layers of the various BEs (Fig. 3a) . A small patch of asthmatic HBEC contained ciliated asthmatic HBEC in a/aBEs cultured for 7 days at the air-liquid interface (Fig.  3a-b) . Similar observations were made on a/naBEs (data not shown). All non-asthmatic HBEC grown in a naBE under the same culture conditions showed a ciliated layer of cells of more elongated morphology (Fig. 3c) . Similar observations were also made in na/aBEs (data not shown). Transmission electron microscopy analyses showed collagen fibers surrounded by bronchial fibroblasts in the mesenchymal layers of the various groups of BEs, but no difference was detected between their matrix ultrastructural features (data not shown).
Ciliogenesis in BEs
Ciliogenesis of the HBEC isolated from non-asthmatic and asthmatic tissues and grown within the different groups of BEs, was assessed by scanning electron microscopy analyses, after 7 days at the air-liquid interface. Ciliogenesis occurred in all HBEC, independently from their tissue of origin. However, longer and more numerous cilia were observed on the apical pole of all non-asthmatic HBEC (Fig. 4a) . In contrast, sparsely distributed shorter cilia (Fig.  4b) were observed on some HBEC isolated from asthmatic tissues, while in some others of the same population, ciliogenesis was comparable to non-asthmatic cells (Fig.  4c) . Thus, ciliogenesis occurred at various stages in the asthmatic HBEC but was higher and more consistently observed in non-asthmatic HBEC, independently of the mesenchymal layers the cells were seeded on.
Conditioned medium
On the basis of several publications reporting the important and beneficial effects of epithelium-mesenchyme interactions through factors secreted and exchanged between both types of tissues Goulet et al., 1996b; Paquette et al., 2003) , the effects of non-asthmatic HBFC was assessed on the growth of non-asthmatic HBEC in na/naBEs and na/aBEs. The growth of the non-asthmatic HBEC in the different BEs, cultured for 7 days under submerged conditions, was assessed by rhodanile red staining. Non-asthmatic HBEC grown on a naBE were used as the positive control corresponding to the highest epithelial cell density observed in absence of CM (Fig. 5, picture 1) . Nonasthmatic HBEC were also grown on two types of mesenchymes containing different asthmatic populations of HBFC (Fig. 5, pictures 2-3) . As expected, the addition of CM on na/naBEs did not improve the growth of the HBEC (data not shown). However, non-asthmatic HBEC, seeded on mesenchymal layers populated with asthmatic HBFC (na/aBEs) and cultured in CM, grew much faster (Fig. 5, pictures 2-3, CM) than the corresponding BEs, cultured in the same medium but not conditioned by the non-asthmatic HBFC (Fig. 5, pictures 2-3) .
Gelatinases secretion by human bronchial cells
Gelatinases A, zymogen of MMP-2 (proMMP-2, 72 kDa), and activated MMP-2 (active MMP-2, 62.5 kDa) and B (MMP-9, 92 kDa) were recently described as secretion products of HBFC and HBEC, respectively (Hoshino et al., 1998) . The gelatinases secreted by the BEs cultured at the air-liquid interface were analyzed by zymography. At least 5 different samples were investigated for each BE tested and we show in Fig. 6 a representative zymogram. Our results showed that the active form of gelatinase A (62.5 kDa) was secreted by all HBFC in the BE supernatants (Fig. 6,  lanes 1-4) , including the supernatant of a/aBEs cultured in presence of CM (Fig.6, lane 4) . The gelatinase B (92 kDa) was also actively secreted by the various HBEC in all BE supernatants (Fig, 6, lanes 1-4) , but the zymograms showed slightly lower activities of this enzyme in the supernatants taken from a/aBEs (Fig. 6, lane 2-4 ), compared to na/naBEs (Fig. 6, lane 1) .
Interestingly, the sample that contained the lowest amounts of gelatinase A (72 kDa), associated with fibroblast secretion products, corresponded to the culture supernatant resolved in lane 3 (Fig. 6) , collected from the a/aBE. This BE showed the thicker mesenchymal layer on histological sections (Fig. 1F) , compared to the other BEs cultured for 6 days at the air-liquid interface. This sample (Fig. 6, lane  3) , was compared to the supernatant of another a/aBE, produced with the same cells, but cultured in presence of medium conditioned by non-asthmatic HBFC (Fig. 6, lane 4) . The CM-stimulated-a/aBE (Fig. 6, lane 4) , contained more of the precursor form of the gelatinase A (72 kDa). It also contained less of the active 62.5 kDa gelatinase than the other BEs (Fig. 6, lanes 1-3) . However, this a/aBE showed a slightly thinner mesenchymal layer on histological analyses than the na/naBEs (Fig. 1A) . Thus, it is difficult to establish a correlation between the amounts of gelatinases secreted in the culture supernatants of the various BEs and the rate of degradation of their mesenchymal layers in culture. Other types of proteases may be involved in this process. 
Discussion
The production of bioengineered BEs with non-asthmatic and asthmatic cells allowed the comparative analyses of severa1 histologic and functional parameters in vitro. Our results suggest that HBEC isolated from asthmatic subjects can grow on a mesenchymal layer seeded with nonasthmatic and asthmatic HBFC. However, if they grow better on a non-asthmatic than on an asthmatic type of mesenchymal layer, they all started to detach from their mesenchymal support one to two days after reaching confluence. Such process continued thereafter, under submerged culture conditions and subsequently, at the air-liquid interface. In contrast, the non-asthmatic HBEC never detached from any type of mesenchymal layer tested. When asthmatic HBEC are grown in monolayers on plastic, they can be maintained in culture for at least 3-4 passages without detaching from the culture dishes, in a medium supplemented with serum. When grown in BEs, their detachment from the various mesenchymal layers, correlates with the formation of holes and the deposition of cell debris at the interface epithelium-mesenchyme. These data suggest that asthmatic HBEC fail to maintain stable points of anchorage with the matrix support, probably due to an absence or a loss of membranous anchorage proteins or receptors. In absence of serum that contains several growth factors and fibronectin, such defect may be observed earlier. We may believe that the behavior of the HBEC isolated from asthmatic subjects seeded on BEs is comparable to the observations reported in asthmatic tissues in vivo when desquamation occurs (Jeffery et al., 1989) .
Ciliogenesis was observed, at least partially, in all groups of BEs. However, several asthmatic HBEC did not show cilia as numerous and/or as long as the non-asthmatic HBEC. These data suggest that the asthmatic HBEC do not reach the same level of differentiation within a given population isolated from the same tissues. Such observations were also reported from histologic analyses of severe asthmatic bronchi, whereas several non-ciliated cells were detected at the surface of their epithelium (Jeffery et al., 1989) . Again, it was not surprising to observe this phenomena in our BE in vitro.
The non-asthmatic HBEC grew more slowly within a na/aBE and the histologic organization of the na/aBEs was less compact than in the na/naBEs. Inversely, the asthmatic HBEC grew faster on a mesenchymal layer containing nonasthmatic HBFC than in a aBE. These data strongly suggest that the HBEC respond to some factors secreted by the HBFC up to a certain degree, and may as well release other factors to the mesenchymal cells. It was previously demonstrated in vitro that epithelial cells are an important regulator of airway remodeling by means of paracrine control of bronchial fibroblasts (Zhang et al., 1999) . Other evidence supporting the existence of epithelium-mesenchyme interactions in the BEs is the positive effect of the CM collected from non-asthmatic HBFC on the growth of nonasthmatic HBEC on a mesenchymal layer seeded with asthmatic HBFC. It seems that the CM contains cytokines that could compensate a lack of factors secreted by the asthmatic HBFC in the na/aBE.
The comparative analyses of the active gelatinases secreted in the BEs culture supernatants showed some differences, but the 92 kDa and the 62.5 kDa gelatinases were detected in all BE supernatants. The supernatant of the a/ aBE showing the thicker mesenchymal layer may be explained by a lower secretion of gelatinase A (72 kDa) or by the synthesis of other collagen types, such as Type V (Hoshino et al., 1998) . The apparent sub-epithelial fibrosis associated with asthma is postulated to be caused by fibroblasts. These cells are involved in collagen synthesis and remodelling and their functional status may be modulated by cytokines secreted by inflammatory or epithelial cells (Brewster et al., 1990; Roche, 1991; Gauldie et al., 1992) . Thus, several hypotheses could be considered to explain our results. The zymograms on gelatin, a substrate rich in collagen Type I, do not reveal several other collagenases and proteases that may be secreted in different amounts by asthmatic and non-asthmatic cells present in our different BEs. It would be interesting to assess the effects of specific inhibitors of MMP-9 and MMP-2 on the maintenance of the mesenchymal layers of the different groups of BEs.
Taken together, we conclude that the tissue-engineered human BE is a good model to investigate cellular mechanisms involved in bronchial disorders like asthma. This approach allows the analyses of several parameters such as the bronchial cell growth and differentiation, their organization and their secretion products in vitro. Comparative toxicological and pharmacological studies of various human bronchial cell populations can be achieved in vitro, using BE as a precious alternative to animal use. Eventually, other cell types, such as immune or smooth muscle cells could be added to the model to investigate more complex interactions.
